T1	Participants 76 111	patients with HCC smaller than 4 cm
T2	Participants 250 321	hepatocellular carcinoma (HCC) ≤ 4 cm, in patients with liver cirrhosis
T3	Participants 345 395	Thirty patients with single HCC ≤ 4 cm in diameter
T4	Participants 445 479	15 patients were treated with PLA,
T5	Participants 570 604	15 patients were treated with RFA,